======= ARPP19 ======= == Gene Information == * **Official Symbol**: ARPP19 * **Official Name**: cAMP regulated phosphoprotein 19 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10776|10776]] * **UniProt**: [[https://www.uniprot.org/uniprot/P56211|P56211]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ARPP19&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ARPP19|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605487|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Protein phosphatase inhibitor that specifically inhibits protein phosphatase 2A (PP2A) during mitosis. When phosphorylated at Ser-62 during mitosis, specifically interacts with PPP2R2D (PR55-delta) and inhibits its activity, leading to inactivation of PP2A, an essential condition to keep cyclin-B1-CDK1 activity high during M phase. May indirectly enhance GAP-43 expression. {ECO:0000269|PubMed:21164014}. |Endosulfine| |phosphatase inhibitor activity| |positive regulation of gluconeogenesis| |protein phosphatase 2A binding| |protein phosphatase regulator activity| |protein phosphatase inhibitor activity| |positive regulation of glucose import| |positive regulation of glucose metabolic process| |potassium channel regulator activity| |positive regulation of glucose transmembrane transport| |regulation of gluconeogenesis| |regulation of glucose import| |positive regulation of cellular carbohydrate metabolic process| |negative regulation of phosphoprotein phosphatase activity| |negative regulation of protein dephosphorylation| |regulation of glucose transmembrane transport| |positive regulation of carbohydrate metabolic process| |regulation of carbohydrate biosynthetic process| |negative regulation of phosphatase activity| |negative regulation of dephosphorylation| |regulation of glucose metabolic process| |regulation of phosphoprotein phosphatase activity| |G2/M transition of mitotic cell cycle| |cell cycle G2/M phase transition| |positive regulation of small molecule metabolic process| |regulation of cellular carbohydrate metabolic process| |regulation of protein dephosphorylation| |regulation of phosphatase activity| |positive regulation of transmembrane transport| |regulation of carbohydrate metabolic process| |regulation of dephosphorylation| |mitotic cell cycle phase transition| |cell cycle phase transition| |signaling receptor binding| |regulation of small molecule metabolic process| |negative regulation of hydrolase activity| |cell division| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |regulation of transmembrane transport| |negative regulation of protein modification process| |mitotic cell cycle process| |mitotic cell cycle| |negative regulation of catalytic activity| |positive regulation of transport| |cell cycle process| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |regulation of hydrolase activity| |cell cycle| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| |regulation of transport| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp293|Myriocin 25μM R06 exp293]]|-1.95| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.443| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13739 * **Expression level (log2 read counts)**: 7.67 {{:chemogenomics:nalm6 dist.png?nolink |}}